Bolt Biotherapeutics, Inc. SEC filings BOLT
Bolt Biotherapeutics, Inc. has 294 filings in SEC EDGAR's recent list, going back to May 7, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, agreement ended, acquisition or sale of assets, unregistered share sale, officer or director change, bylaw or fiscal year change, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 7, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2022 | — |
| CORRESP | Letter to the SEC | Apr 5, 2022 | — |
| D | Filing | Jun 7, 2021 | — |
| EFFECT | Filing | Feb 4, 2021 | — |
| CERT | Filing | Feb 4, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 3, 2021 | — |
| CORRESP | Letter to the SEC | Feb 2, 2021 | — |
| CORRESP | Letter to the SEC | Feb 2, 2021 | — |
| 8-A12B | Filing | Feb 2, 2021 | — |
| D | Filing | Jan 28, 2021 | — |
| CORRESP | Letter to the SEC | Jan 25, 2021 | — |
| DRSLTR | Filing | Jan 11, 2021 | — |
| DRS/A | Filing | Jan 11, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 15, 2020 | — |
| DRS/A | Filing | Sep 11, 2020 | — |
| DRSLTR | Filing | Sep 10, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2020 | — |
| DRS | Filing | Aug 10, 2020 | — |
| D | Filing | Jul 15, 2019 | — |
| D | Filing | Aug 6, 2018 | — |
| D | Filing | Feb 20, 2018 | — |
| D | Filing | Sep 30, 2016 | — |
| D | Filing | May 7, 2015 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BOLT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1641281
- Former names
- Bolt Therapeutics, Inc. (until May 7, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.